[Federal Register Volume 67, Number 177 (Thursday, September 12, 2002)]
[Notices]
[Page 57826]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-23152]



[[Page 57826]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Vaccine Advisory Committee, Subcommittee on Future 
Vaccines, Subcommittee on Immunization Coverage, and Subcommittee on 
Vaccine Safety and Communication Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meetings.

    Name: National Vaccine Advisory Committee (NVAC).
    Times and Dates: 9 a.m.-3 p.m., October 8, 2002. 8:30 a.m.-3 
p.m., October 9, 2002.
    Place: Hubert H. Humphrey Building, Room 705A, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Notice: In the interest of security, the Department has 
instituted stringent procedures for entrance to the Hubert H. 
Humphrey Building by non-government employees. Thus, persons without 
a government identification card should plan to arrive at the 
building each day either between 8 a.m. and 8:30 a.m. or 12:30 p.m. 
and 1 p.m. Entrance to the meeting at other times during the day 
cannot be assured.
    Purpose: This committee advises and makes recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program responsibilities.
    Matters To Be Discussed: Agenda items will include: A report 
from the National Vaccine Program Office (NVPO) and the Interagency 
Vaccine Workgroup; a report from the Assistant Secretary for Health; 
discussion on a proposal for a workshop on traveler's vaccines; an 
update on the Influenza Pandemic Preparedness Plan; an update on 
vaccine supply; a discussion of compensation for vaccine 
administration: Center for Medicare and Medical Services Ruling; a 
discussion of international vaccine development and introduction; an 
update on immunization registries; a discussion of racial and ethnic 
disparities in adult immunization rates; Polio Laboratory 
Containment and ramifications of recent synthesis of poliovirus; 
Vaccine Safety and Communication Subcommittee report; Immunization 
Coverage Subcommittee report, Future Vaccines Subcommittee report; 
Increasing Public Participation in Dialogue and Deliberation About 
Vaccines--Report from Wingspread; discussions on Smallpox Vaccine 
Development and DHHS Smallpox Vaccine Policy; Institute of Medicine 
(IOM) Report--Vaccine Financing, also an update on the IOM Safety 
Review Committee; reports from Advisory Committee Immunization 
Practices/NVAC Smallpox Working Group--Update, Advisory Commission 
on Childhood Vaccines/Division of Vaccine Injury Compensation, 
Vaccine Related Biological Products Advisory Committee/Food and Drug 
Administration, Advisory Committee on Immunization Practices/
National Immunization Program/National Center for Infectious 
Diseases.

    Name: Subcommittee on Future Vaccines.
    Time and Date: 3:15 p.m.-5 p.m., October 8, 2002.
    Place: Hubert H. Humphrey Building, Room 405A, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee develops policy options and guides 
national activities that lead to accelerated development, licensure, 
and the best use of new vaccines in the simplest possible 
immunization schedules.
    Matters To Be Discussed: Agenda items will be; a discussion on 
Planning for a meeting on Pneumococcal Vaccinations for Adults; a 
report on the CMV meeting; a discussion of potential future topics, 
Cell-culture based influenza vaccine, Implications of vectored 
vaccines.
    Name: Subcommittee on Immunization Coverage.
    Time and Date: 3:15 p.m.-5 p.m., October 8, 2002.
    Place: Hubert H. Humphrey Building, Room 705A, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee will identify and propose solutions 
that provide a multifaceted and holistic approach to reducing 
barriers that result in low immunization coverage for children.
    Matters To Be Discussed: Agenda items will include discussions 
on the updates on Publication of Adult and Pediatric Standards; IOM 
Study on Financing Vaccines; Influenza Immunization Study/READII; 
Registry for missed immunizations; Areas of Unmet Needs.

    Name: Subcommittee on Vaccine Safety and Communication.
    Time and Date: 3:15 p.m.-5 p.m. October 8, 2002.
    Place: Hubert H. Humphrey Building, Room 425A, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee reviews issues relevant to vaccine 
safety and adverse reactions to vaccines.
    Matters To Be Discussed: Influenza communications programs; a 
progress report from the IOM Vaccine Safety Review; and a progress 
report about changes in the Vaccine Injury Compensation Program; a 
report about Thimerosal class action suits.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Gloria Sagar, Committee 
Management Specialist, NVPO, CDC, 4700 Buford Highway M/S K-77, 
Chamblee, Georgia 30341, telephone 770/488-2040.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: September 6, 2002.
John Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 02-23152 Filed 9-11-02; 8:45 am]
BILLING CODE 4163-18-M